The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP): A prospective German registry in stage IV NSCLC AIO-TRK-0315.
 
Frank Griesinger
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Roche/Genentech
Research Funding - AstraZeneca (Inst)
 
Wilfried Ernst Erich Eberhardt
No Relationships to Disclose
 
Norbert Marschner
No Relationships to Disclose
 
Martina Jänicke
No Relationships to Disclose
 
Lisa Spring
No Relationships to Disclose
 
Joerg Sahlmann
No Relationships to Disclose
 
Aysun Karatas
No Relationships to Disclose
 
Annette Hipper
No Relationships to Disclose
 
Martin Sebastian
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer
 
Michael Thomas
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche